Investigating how Checkpoint kinase 2 affects immune response in gliomas
Official title: The immunosuppressive function of Checkpoint kinase 2 in gliomas
Funded at Northwestern University at Chicago · NIH-10944895 · Data updated 2026-11-12
This study is looking at how glioma tumors manage to hide from the immune system and whether blocking a specific protein called Chek2 can help make current treatments work better for patients with these tumors.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | September 19, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $400,000 |
| NIH project number | 1R01NS138769-01 |
| Project ID | NIH-10944895 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with gliomas, particularly those who have not responded well to current treatments.
✕Less likely to help
Patients with gliomas who are not eligible for immunotherapy or those with other types of brain tumors may not benefit from this research.
What this research studies
This research focuses on understanding how glioma tumors evade the immune system, particularly the role of Checkpoint kinase 2 (Chek2) in this process. By using advanced techniques like CRISPR screening, the researchers aim to identify how Chek2 contributes to the tumor's ability to resist being attacked by CD8 T cells, a type of immune cell. The study will explore the interactions between Chek2 and specific proteins that regulate immune responses, and it will test whether inhibiting Chek2 can enhance the effectiveness of existing immunotherapies. This could lead to new treatment strategies for patients with gliomas.
Why it matters
Potential benefit: If successful, this research could lead to improved immunotherapy options for patients with gliomas, potentially enhancing their survival rates.
How similar studies have gone: Previous research has shown promising results in targeting similar pathways in gliomas, indicating potential for success with this approach.
Where this research is happening
-
Northwestern University at Chicago
Chicago, United States Active
Researchers
- Principal investigator: Dmello, Crismita Clement — Northwestern University at Chicago
- Study coordinator: Dmello, Crismita Clement
Related research
Other NIH-funded projects on the same topics.
-
High-intensity exercise as a treatment for Parkinson's disease
This study is looking at whether doing high-intensity endurance exercise can help people who have just been diagnosed with Parkinson's disease feel better and slow down their symptoms, especially since current medications don't always do the trick.
-
Software to quickly assess organ dose after radionuclide exposure
This study is creating a helpful software tool that quickly calculates how much radiation your organs absorb after you've taken certain radioactive substances, so you can get better care and treatment based on your individual needs.
-
Investigating innovative approaches to improve health outcomes.
This study is looking for better ways to improve your care and treatment, so you can get more personalized options that work best for you.
-
Investigating innovative approaches to improve health outcomes.
This study is looking for new ways to improve care and treatment for patients, and if you join, you might help test some exciting new methods that could lead to better health for everyone.
-
Investigating innovative approaches to improve health outcomes.
This study is looking for ways to improve care and treatment for patients like you, by trying out new methods that could help manage your health better.
-
Investigating core biological processes
This study is all about exploring important biological processes that affect our health, and it invites patients to help discover new ways to improve care for everyone.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.